Tempus ECG-AF vs VitalConnect VitalPatch
AI Verdict
Choose Tempus ECG-AF if…
Choose Tempus ECG-AF if your primary objective is to proactively identify patients aged 65 or older who are at an increased risk of developing new-onset atrial fibrillation within the next 12 months, utilizing a standard 12-lead ECG. This tool is ideal for integrating into routine cardiology or geriatrics workflows to support early intervention strategies and targeted follow-up for at-risk individuals.
View Tempus ECG-AF →Choose VitalConnect VitalPatch if…
Choose VitalConnect VitalPatch if you require continuous, real-time monitoring of multiple vital signs and cardiac arrhythmias for patients, whether in-hospital or remotely. This wearable biosensor is best suited for scenarios demanding immediate detection of physiological changes and arrhythmias over an extended period, facilitating timely clinical intervention and comprehensive patient oversight.
View VitalConnect VitalPatch →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Tempus ECG-AF | VitalConnect VitalPatch |
|---|---|---|
| Pricing | Contact vendor | Contact for pricing |
| Deployment | Software solution, integrated into healthcare facility systems with advanced cardiology algorithms. | Cloud-based with wearable biosensor and patient-carried relay devices (VistaPhone/VistaTablet). |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Yes AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
VitalConnect VitalPatchVitalConnect VitalPatch offers a wearable biosensor designed for continuous, real-time monitoring, emphasizing patient comfort with features like water resistance, a 7-day wear period, and hypoallergenic adhesive. This patient-centric design, along with clear instructions for use, suggests a higher degree of practical usability for both patients and clinicians managing remote monitoring.
Clinical Value
VitalConnect VitalPatchVitalConnect VitalPatch provides real-time, continuous monitoring of up to 11 vital signs and detects 21 cardiac arrhythmias using AI, offering broad and immediate clinical utility for active patient management and surveillance. In contrast, Tempus ECG-AF offers a predictive risk assessment for new-onset AF within 12 months from a single ECG, which is valuable but more focused and less immediate in its clinical application.
Pricing & Value
Tempus ECG-AFTempus ECG-AF provides specific CMS reimbursement CPT codes (0764T and 0765T) and a clear Medicare rate of $128.90, effective January 1, 2025. This transparency regarding reimbursement offers a more concrete understanding of the financial value and revenue potential for healthcare providers compared to VitalConnect's general mention of subscription-based services and wide coverage.
Enterprise Readiness
Tempus ECG-AFTempus ECG-AF is described as a 'software solution, integrated into healthcare facility systems,' suggesting a streamlined integration into existing IT infrastructure and clinical workflows. While both are FDA-cleared and HIPAA compliant, VitalConnect's reliance on wearable biosensors and patient-carried relay devices introduces additional logistical complexities for large-scale enterprise deployment and device management.
Innovation
Tempus ECG-AFTempus ECG-AF demonstrates significant innovation by leveraging AI to predict the risk of new-onset atrial fibrillation within 12 months from a standard 12-lead ECG. This predictive capability from a static diagnostic test represents a novel approach to proactive disease management, offering a new paradigm in identifying at-risk patients.
Support & Docs
VitalConnect VitalPatchVitalConnect offers comprehensive support resources, including detailed Instructions for Use for patients and clinicians, instructional videos, dedicated phone lines for various support needs (general, returns, billing), and an IT Administration Guide. This extensive and easily accessible documentation and support infrastructure surpasses the specific support information found for Tempus ECG-AF.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Tempus ECG-AF | VitalConnect VitalPatch |
|---|---|---|
| Name | Tempus ECG-AF | VitalConnect VitalPatch |
| Company | Tempus AI, Inc. | VitalConnect |
| Description | FDA-cleared AI-based algorithm that analyzes 12-lead ECG recordings to identify patients aged 65 or older at increased risk of developing atrial fibrillation/flutter (AF) within the next 12 months, supporting earlier identification and follow-up. | Wearable biosensor and cloud-based platform for real-time, continuous monitoring of vital signs and cardiac arrhythmias for healthcare professionals, enabling remote patient monitoring and in-hospital care. |
| Key Functionality | AI-based algorithm for 12-lead ECG analysis to detect signs associated with new onset Atrial Fibrillation (AF) within 12 months. | Wearable biosensor for continuous monitoring and real-time streaming of up to 11 vital signs, including live ECG, and detection of 21 cardiac arrhythmias using AI algorithms. |
| Target Patient Population | Patients 65 years or older without pre-existing AF, pacemakers, ICDs, or recent cardiac surgery. | Not specified |
Videos
Demos, reviews, and walkthroughs featuring Tempus ECG-AF and VitalConnect VitalPatch.
Frequently Asked Questions
More Comparisons
More matchups featuring Tempus ECG-AF or VitalConnect VitalPatch
Backers
Who funded each tool's parent company.